Mandatory Product Information

Relfydess is a prescription medicine containing 150 units/1.5 mL botulinum toxin type A. It is used for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. Relfydess has risks and benefits. Ask your doctor if Relfydess is right for you. Do not use if you are allergic to botulinum toxin or any ingredients in Relfydess, have an infection at the planned injection site, or are pregnant or breastfeeding. Tell your doctor about all medicines you are taking. Side effects may include headache, bruising, eyelid drooping, and injection site reactions. For more information, consult your doctor or see the Consumer Medicine Information at www.medsafe.govt.nz. IPSEN LIMITED. Unfunded. Treatment costs apply.

Botox is a prescription medicine containing 100 units of Clostridium Botulinum Type A toxin complex. It is used for the treatment of frown lines, crow's feet, forehead lines, excessive sweating of the armpits, chronic migraine, and other approved indications. Botox has risks and benefits. Ask your doctor if Botox is right for you. Do not use if you are allergic to any ingredient in Botox, have an infection at the proposed injection site, or are pregnant or breastfeeding. Tell your doctor about all medicines you are taking, especially aminoglycoside antibiotics or muscle relaxants. Possible side effects include headache, pain or bruising at the injection site, eyelid drooping, and temporary muscle weakness. Allergan (NZ) Limited, Auckland. For product information, check with your doctor or the Consumer Medicine Information on www.medsafe.govt.nz. Prescription medicine. Unfunded. Treatment costs apply.

Profhilo, containing low and high molecular weight hyaluronic acid, is a Class III medical device for the treatment of the face and body for contours redefinition and laxity remodelling where skin laxity is a problem. Profhilo has risks and benefits. Do not use with treatments such as laser resurfacing or medium-deep skin-peeling. Caution in people on blood thinning medicines. Do not inject into inflamed areas or intravenously or intramuscularly. Possible side effects: pain and swelling at injection site. Accelagen Pty. Ltd. Whanganui.

REJURAN is a Class III Medical Device designed for tissue restoration, reconstruction, and improvement of physical appearance. REJURAN has both risks and benefits. Consult your medical practitioner to determine if REJURAN injectables are right for you. Each injection contains 20mg/ml of stabilised polynucleotides (PN). For product information, refer to your medical practitioner or the supplier's product details. Always follow your medical practitioner's instructions. This medical device must be administered by a trained professional. Unfunded in New Zealand. Product and treatment costs apply.

HILO WAVE is a medical device containing Dual Hyaluronic Acid (H-HA and L-HA) used as a bio-stimulator to improve overall skin quality and restore volume. Treatment with HILO WAVE carries both risks and benefits. While it helps activate collagen production and hydrate the skin, potential side effects can include temporary redness, swelling, bruising, or pain at the injection site. Rare complications include infection, nodules, or allergic reactions. Do not use if you have an active skin infection, inflammation, bleeding disorders, poor wound healing, active auto-immune disease, or a history of severe allergies or keloid scarring. Treatment is not suitable if you are pregnant, breastfeeding, or under 18 years of age. This medical device must be administered exclusively by a trained Healthcare Professional. Always consult your practitioner to see if HILO WAVE is right for you and carefully review the treatment implications before proceeding. Out-of-pocket costs and regular maintenance treatments apply. Distributed in New Zealand by Athena Biomed.

Sunekos containing hyaluronic acid and amino acids is a class III medical device that modifies the structure of mature skin, restoring volume, filling wrinkles and folds in the skin and in scar sites. Sunekos has risks and benefits. Sunekos should not be used on patients with known hypersensitivity to any of its components, presenting with a general infection, inflammation or irritation in the area to be treated, or in patients predisposed to coagulation disorders. A local reaction may rarely occur, caused by hypersensitisation phenomena, with symptoms that include oedema and sensation of burning and/or itching. These reactions normally resolve within two days. Consult your healthcare professional to see if Sunekos is right for you. For more information refer to the instructions for use. New Zealand Sponsor: AA-Med Pty Ltd. Distributed by: Xytide Biotech NZ Pty Ltd.

NCTF 135 HA is a non-prescription medical device containing non-crosslinked Hyaluronic Acid combined with a polyrevitalising solution (vitamins, amino acids, coenzymes, and antioxidants) used in aesthetic treatments to support skin quality, hydration, and superficial wrinkles. Treatment with NCTF 135 HA carries both risks and benefits. Benefits include enhanced skin radiance and hydration. Potential side effects include temporary local reactions such as redness, bruising, swelling, mild pain, or micro-papules at the injection or microneedling site. Rare risks include infection or localised hypersensitivity reactions. This treatment is not suitable for individuals with active skin infections, inflammation, severe skin diseases, a history of autoimmune disease, or known hypersensitivity to hyaluronic acid or any of the product's components. It must not be used on patients who are pregnant, breastfeeding, or under the age of 18. This medical device must be administered exclusively by a qualified healthcare professional. Individual results may vary. A clinical consultation is mandatory prior to treatment to determine your suitability. Additional out-of-pocket fees and ongoing maintenance sessions apply. For further product information, consult your practitioner or visit Medsafe New Zealand at www.medsafe.govt.nz.

Skinfill Bacio is a medical device containing 20mg/ml of non-cross-linked hyaluronic acid combined with Vitamin B12, formulated specifically for the lips to hydrate, refine and revitalise lip tissue without adding significant volume. Skinfill Bacio has risks and benefits. Do not use if you have known hypersensitivity to hyaluronic acid or any of its components, have an active infection or inflammation in or around the lips, have a history of severe allergies or keloid scarring, or are pregnant or breastfeeding. Possible side effects include temporary swelling, redness, bruising, tenderness or small lumps at the injection site. Consult your healthcare professional to see if Skinfill Bacio is right for you and to discuss the full risks and benefits before proceeding. Manufactured by Promoitalia, Italy. This medical device must be administered exclusively by a trained healthcare professional. Unfunded in New Zealand. Product and treatment costs apply.

Jalupro is a medical device containing a combination of amino acids (glycine, proline, leucine and lysine) and low molecular weight sodium hyaluronate, used to biorevitalise the skin, improve hydration and elasticity, and support the skin's own collagen and elastin production. Jalupro has risks and benefits. Do not use if you have known hypersensitivity to any of its components, have an active skin infection or inflammation in the treatment area, have a bleeding or clotting disorder, or are pregnant or breastfeeding. Possible side effects include temporary redness, swelling, bruising, tenderness or small lumps at the injection site. Consult your healthcare professional to see if Jalupro is right for you and to discuss the full risks and benefits before proceeding. Manufactured by Professional Derma SA, Switzerland. This medical device must be administered exclusively by a trained healthcare professional. Unfunded in New Zealand. Product and treatment costs apply.

PROFHILO STRUCTURA is a class 3 medical device and must be injected by a medical practitioner or a qualified nurse injector (operating under the supervision of a medical practitioner). PROFHILO STRUCTURA [4.5% 22.5 mg (H-HA) + 22.5 mg (L-HA)/1 ml Hyaluronic acid sodium salt and 4.5% 45 mg (H-HA) + 45 mg (L-HA)/2 ml Hyaluronic acid sodium salt], injection gel in a single use sterile prefilled syringe. It is indicated for adults of both sexes for corrective/filling action of natural or induced skin depressions. PROFHILO STRUCTURA has risks and benefits. Ask your healthcare professional if PROFHILO STRUCTURA is right for you and to explain the possible side effects. WARNINGS AND PRECAUTIONS: Do not use PROFHILO STRUCTURA in case of known hypersensitivity or allergies to the components of the product. Do not use it in pregnant or breast-feeding women, in patients with autoimmune diseases. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. CONTRAINDICATIONS: PROFHILO STRUCTURA must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. Tell your doctor if any side effects concern you. ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. Treatment costs and normal practitioner fees will apply. Please contact us for any further information or for the IFU (Instructions for use) of this product or for medical information or reporting any adverse effects. Phone: 0800 603 906 Email: info@dermocosmetica.com.au Web: www.ibsaderma.co.nz TAPS Approval BG4145 26 July 2024. Distributed in New Zealand by Dermocosmetica (NZBN 9429050049066) Suite A, Floor 8 Harbourview Building, 152 Quay St, Auckland Central, Auckland, New Zealand, through Healthcare Logistics, 58 Richard Pearse Drive, Airport Oaks, Manukau City, Auckland, New Zealand.

Sunekos Performa is a sterile resorbable injectable solution which acts as a filler, supporting the restoration of physiological elasticity and temporarily replacing volume by expanding the soft tissues. Sunekos should not be used on patients with known hypersensitivity to any of its components, presenting with a general infection, inflammatory or infectious cutaneous problems, with history of severe multiple allergies or anaphylactic shock, prone to hypertrophic scars/keloids or streptococcal diseases, in patients presenting with porphyria, under 18 years of age, in pregnancy or lactation. See full Instructions for use before prescribing for full safety information, available from www.xytide.co.nz. New Zealand Sponsor: AA-Med Pty Ltd. Distributed by: Xytide Biotech NZ Pty Ltd (NZBN 9429049668612) C/O Alliott Ltd, Level 2, 142 Broadway, Newmarket, Auckland 1023 NZ.